| |
ski properties for sale in bansko
News and Information Article
PALO ALTO, Calif., Aug. 10 /-FirstCall/ -- Hercules
Technology Growth Capital, Inc. (Nasdaq: HTGC), a leading specialty finance
company providing debt and equity growth capital to venture capital and
private equity backed technology and life science companies, announced that
on Aug. 3, 2006 it provided $8.0 million of debt financing to Novasys
Medical, Inc., a developer of innovative therapies in womens health.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050609/SFTH149LOGO )
Novasys Medical recently launched its first FDA cleared product, the
Renessa(TM) System, a proprietary, non-surgical treatment for female stress
urinary incontinence (SUI). This unique product offers women and their
physicians an innovative, non-incisional treatment that can be performed in
a physicians office or other outpatient setting, presenting an alternative
to patients who do not want surgery to treat SUI. The Renessa procedure
uses radiofrequency energy (RF) to generate controlled heat at low
temperatures in tissue targets within the lower urinary tract. The heat
denatures collagen in the tissue at multiple small treatment sites.
"We are excited to be an investor in this innovative technology," said
Kathy Conte, managing director of life sciences at Hercules. "In partnering
with Novasys around womens health technology, we have reaffirmed our
commitment to the growth prospects in this industry. This investment is a
natural fit into our portfolio of womens health investments."
"We are very pleased to partner with Hercules and to add its financing
strength to our group of experienced and supportive investors," said Debra
Reisenthel, president and CEO of Novasys Medical. "The $8.0 million of debt
financing provided by Hercules supports us as we continue to expand our
product commercialization efforts."
SUI is the involuntary leakage of urine associated with coughing,
sneezing, sexual and recreational activities. The condition is caused by a
variety of factors, most commonly childbirth, and often restricts the
social, professional and personal lives of an estimated 15 million women in
the U.S. alone.
About Hercules Technology Growth Capital, Inc.:
Founded in December 2003, Hercules Technology Growth Capital, Inc. is a
NASDAQ traded specialty finance company providing debt and equity growth
capital to technology-related companies at all stages of development. The
company primarily finances privately-held companies backed by leading
venture capital and private equity firms and also may finance certain
publicly-traded companies. Hercules focuses its investments in companies
active in technology and technology-related industries such as computer
software and hardware, networking systems, semiconductors, semiconductor
capital equipment, information technology infrastructure, Internet consumer
and business services, telecommunications, and life sciences. The companys
investments are originated through its principal office located in Silicon
Valley, as well as additional offices in the Boston, Boulder and Chicago
areas. Providing capital to publicly traded or privately held companies
backed by leading venture capital and private equity firms involves a high
degree of credit risk and may result in potential losses of capital.
For more information, please visit http://www.herculestech.com . Companies
interested in learning more about financing opportunities should contact
info@herculestech.com or call 650.289.3060.
About Novasys Medical, Inc.:
Novasys Medical, Inc. is a privately held, venture-backed company which
develops innovative therapies in womens health. The companys initial
focus is the development and commercialization of the Renessa(TM) System, a
proprietary, non-surgical approach to the treatment of female stress
urinary incontinence (SUI). The Renessa treatment can be performed in a
physicians office or an outpatient center. For more information, please
visit http://www.novasysmedical.com or call (510) 226-4060.
Forward-Looking Statements:
The statements contained in this release that are not purely historical
are forward-looking statements. These forward-looking statements are not
guarantees of future performance and are subject to uncertainties and other
factors that could cause actual results to differ materially from those
expressed in the forward-looking statements including, without limitation,
the risks, uncertainties and other factors we identify from time to time in
our filings with the Securities and Exchange Commission. Although we
believe that the assumptions on which these forward-looking statements are
reasonable, any of those assumptions could prove to be inaccurate and, as a
result, the forward-looking statements based on those assumptions also
could be incorrect. You should not place undue reliance on these
forward-looking statements. The forward-looking statements contained in
this release are made as of the date hereof, and Hercules assumes no
obligation to update the forward-looking statements for subsequent events.
Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Kathy Conte
http://profnet.prnewswire.com/ud_public.jsp?userid=10031089
| |
|
|
 |
ski properties for sale in bansko |
|
|
|
|
|
|
|
|
|
Locations
